ePVA Monitoring System for Head and Neck Cancer

N/A

Recruiting

Led By Janet H. Van Cleave, PhD, RN

Research Sponsored by The University of Texas Health Science Center, Houston

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Individuals with histologically diagnosed head and neck cancer (HNC) undergoing curative radiation therapy with or without chemotherapy

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 4 weeks after completing radiation therapy

Awards & highlights

No Placebo-Only Group

Summary

This trial tests a digital monitoring system to help detect uncontrolled symptoms in patients with head and neck cancer and provide timely interventions.

Who is the study for?

This trial is for English or Spanish speaking individuals with confirmed head and neck cancer, undergoing curative radiation therapy, with or without chemotherapy. It's also for clinicians treating these patients. People who don't meet these specific criteria are excluded.

What is being tested?

The study tests the NYU Electronic Patient Visit Assessment (ePVA), a digital system for monitoring symptoms in real-time against usual care methods. The goal is to see if ePVA improves swallowing, taste, smell, and social functions after radiation therapy.

What are the potential side effects?

Since this trial involves patient-reported outcomes rather than medication or invasive procedures, there are no direct side effects from interventions like drugs or surgery. However, participants may experience discomfort when discussing sensitive health issues.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I have head and neck cancer and am receiving radiation to cure it, with or without chemotherapy.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 4 weeks after completing radiation therapy

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~4 weeks after completing radiation therapy

This trial's timeline: 3 weeks for screening, Varies for treatment, and 4 weeks after completing radiation therapy for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Head and neck cancer (HNC) symptoms as assessed by the European Organization for Research and Treatment of Cancer (EORTC) Quality of Life Questionnaires (QLQ)

Secondary study objectives

Acute Care Services Use as assessed by number of acute care visits

Acute Care Services Use as assessed by number of days of using acute care

Health-Related Quality of Life (HRQoL) as assessed by the EORTC QLQ-C30 Quality of Life Questionnaire (QLQ)

+1 more